You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

BREVITAL SODIUM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Brevital Sodium, and when can generic versions of Brevital Sodium launch?

Brevital Sodium is a drug marketed by Endo Operations and is included in one NDA.

The generic ingredient in BREVITAL SODIUM is methohexital sodium. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the methohexital sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Brevital Sodium

A generic version of BREVITAL SODIUM was approved as methohexital sodium by STERISCIENCE on October 3rd, 2024.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for BREVITAL SODIUM?
  • What are the global sales for BREVITAL SODIUM?
  • What is Average Wholesale Price for BREVITAL SODIUM?
Summary for BREVITAL SODIUM
Drug patent expirations by year for BREVITAL SODIUM
Drug Prices for BREVITAL SODIUM

See drug prices for BREVITAL SODIUM

Recent Clinical Trials for BREVITAL SODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mayo ClinicN/A

See all BREVITAL SODIUM clinical trials

Pharmacology for BREVITAL SODIUM
Drug ClassBarbiturate

US Patents and Regulatory Information for BREVITAL SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Endo Operations BREVITAL SODIUM methohexital sodium INJECTABLE;INJECTION 011559-002 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Endo Operations BREVITAL SODIUM methohexital sodium INJECTABLE;INJECTION 011559-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Endo Operations BREVITAL SODIUM methohexital sodium INJECTABLE;INJECTION 011559-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Endo Operations BREVITAL SODIUM methohexital sodium INJECTABLE;INJECTION 011559-004 Dec 21, 2012 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.